BR100 Increased By (0.45%)
BR30 Increased By (0.39%)
KSE100 Increased By (0.22%)
KSE30 Increased By (0.1%)
BECO 5.90 Decreased By ▼ -0.13 (-2.16%)
BML 57.80 Increased By ▲ 5.05 (9.57%)
BOP 34.00 Decreased By ▼ -0.25 (-0.73%)
CNERGY 8.20 Increased By ▲ 0.04 (0.49%)
DCL 12.09 Decreased By ▼ -0.25 (-2.03%)
FCCL 53.96 Increased By ▲ 0.07 (0.13%)
FCSC 5.26 Increased By ▲ 0.04 (0.77%)
FFL 18.00 Decreased By ▼ -0.03 (-0.17%)
FNEL 1.31 Increased By ▲ 0.01 (0.77%)
HUMNL 11.45 Increased By ▲ 0.45 (4.09%)
KEL 8.17 Increased By ▲ 0.06 (0.74%)
KOSM 5.45 Increased By ▲ 0.07 (1.3%)
MLCF 88.62 Increased By ▲ 0.57 (0.65%)
NBP 186.70 Increased By ▲ 0.22 (0.12%)
PACE 11.07 Increased By ▲ 0.35 (3.26%)
PAEL 40.40 Increased By ▲ 0.46 (1.15%)
PIAHCLA 26.44 Increased By ▲ 0.27 (1.03%)
PIBTL 17.37 Increased By ▲ 0.05 (0.29%)
PPL 232.50 Decreased By ▼ -0.28 (-0.12%)
PRL 34.98 Increased By ▲ 0.03 (0.09%)
PTC 67.25 Decreased By ▼ -0.31 (-0.46%)
SEARL 91.45 Increased By ▲ 0.52 (0.57%)
SSGC 27.02 Decreased By ▼ -0.15 (-0.55%)
TELE 8.58 Increased By ▲ 0.01 (0.12%)
THCCL 65.50 Increased By ▲ 5.37 (8.93%)
TPLP 9.18 Increased By ▲ 0.42 (4.79%)
TREET 24.66 Increased By ▲ 0.12 (0.49%)
TRG 72.41 Increased By ▲ 0.66 (0.92%)
WAVES 10.98 Increased By ▲ 1.00 (10.02%)
WTL 1.27 Increased By ▲ 0.01 (0.79%)
World

Russia's Sputnik V shot around 90pc effective against Delta variant

  • The shot was previously found by the researchers to be almost 92% effective against the original strain of coronavirus.
Published June 29, 2021 Updated June 29, 2021 04:53pm
By

MOSCOW: Russia's Sputnik V vaccine is around 90% effective against the Delta variant of coronavirus, the RIA news agency cited Denis Logunov, deputy director of the Gamaleya Institute that developed the vaccine, as saying on Tuesday.

The shot was previously found by the researchers to be almost 92% effective against the original strain of coronavirus.

Logunov said the Delta variant efficacy figure was calculated based on information from digital medical records and on vaccination records.

Comments

Comments are closed for this article.